George Dan 4
4 · Lucira Health, Inc. · Filed Feb 9, 2021
Insider Transaction Report
Form 4
George Dan
CFO and Treasurer
Transactions
- Conversion
Series B Preferred Stock
2021-02-09−10,725→ 0 total→ Common Stock (10,725 underlying) - Conversion
Series C Preferred Stock
2021-02-09−13,288→ 0 total→ Common Stock (13,288 underlying) - Conversion
Common Stock
2021-02-09+10,725→ 15,365 total - Conversion
Common Stock
2021-02-09+13,288→ 28,653 total
Footnotes (1)
- [F1]Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.